Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation

Journal of the American Academy of Dermatology

Volumn 58, Issue 5, 2008, Pages 802-809

  Kitamura, Kana ^a   Asada, Hideo ^a   Iida, Hideyuki ^a   Fukumoto, Takaya ^a   Kobayashi, Nobuhiko ^a   Niizeki, Hironori ^a   Morii, Takeshi ^a   Kimura, Hiroshi ^a   Miyagawa, Sachiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN TISSUE; MALE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; REAL TIME POLYMERASE CHAIN REACTION; SKIN MANIFESTATION; VIRUS REACTIVATION;

ADULT; AGED; DNA, VIRAL; EXANTHEMA; FEMALE; GRAFT VS HOST DISEASE; HERPESVIRUS 6, HUMAN; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 41949109939     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.01.005     Document Type: Article

References (28)

1. Sashihara J., Tanaka-Taya K., Tanaka S., Amo K., Miyagawa H., Hosoi G., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100 (2002) 2005-2011
2. Reusser P., Einsele H., Lee J., Volin L., Rovira M., Engelhard D., et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99 (2002) 1159-1164
3. Yoshikawa T. Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 124 (2004) 421-432
4. Yoshikawa T., Suga S., Asano Y., Nakashima T., Yazaki T., Sobue R., et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 78 (1991) 1381-1384
5. Appleton A.L., Sviland L., Peiris J.S., Taylor C.E., Wilkes J., Green M.A., et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. Bone Marrow Transplant 16 (1995) 777-782
6. Yoshikawa T., Ihira M., Ohashi M., Suga S., Asano Y., Miyazaki H., et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 28 (2001) 77-81
7. Boutolleau D., Fernandez C., Andre E., Imbert-Marcille B.M., Milpied N., Agut H., et al. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187 (2003) 179-186
8. Cone R.W., Hackman R.C., Huang M.L., Bowden R.A., Meyers J.D., Metcalf M., et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329 (1993) 156-161
9. Cone R.W., Huang M.L., Corey L., Zeh J., Ashley R., and Bowden R. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 179 (1999) 311-318
10. Wang F.Z., Dahl H., Linde A., Brytting M., Ehrnst A., and Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 88 (1996) 3615-3620
11. Matsuda Y., Hara J., Miyoshi H., Osugi Y., Fujisaki H., Takai K., et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant 24 (1999) 919-923
12. Buchbinder S., Elmaagacli A.H., Schaefer U.W., and Roggendorf M. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 26 (2000) 639-644
13. Imbert-Marcille B.M., Tang X.W., Lepelletier D., Besse B., Moreau P., Billaudel S., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 31 (2000) 881-886
14. Ljungman P., Wang F.Z., Clark D.A., Emery V.C., Remberger M., Ringden O., et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 111 (2000) 774-781
15. Zerr D.M., Gooley T.A., Yeung L., Huang M.L., Carpenter P., Wade J.C., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33 (2001) 763-771
16. Yoshikawa T., Asano Y., Ihira M., Suzuki K., Ohashi M., Suga S., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 185 (2002) 847-853
17. Volin L., Lautenschlager I., Juvonen E., Nihtinen A., Anttila V.J., and Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 126 (2004) 690-696
18. Savolainen H., Lautenschlager I., Piiparinen H., Saarinen-Pihkala U., Hovi L., and Vettenranta K. Human herpesvirus-6 and -7 in pediatric stem cell transplantation. Pediatr Blood Cancer 45 (2005) 820-825
19. Gondo H., Harada M., Taniguchi S., Akashi K., Hayashi S., Teshima T., et al. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease. Bone Marrow Transplant 12 (1993) 437-441
20. Tanaka N., Kimura H., Iida K., Saito Y., Tsuge I., Yoshimi A., et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 60 (2000) 455-462
21. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1 (1988) 1065-1067
22. Okuno T., Higashi K., Shiraki K., Yamanishi K., Takahashi M., Kokado Y., et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 49 (1990) 519-522
23. Carrigan D.R., Drobyski W.R., Russler S.K., Tapper M.A., Knox K.K., and Ash R.C. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338 (1991) 147-149
24. Suzuki Y., Inagi R., Aono T., Yamanishi K., and Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134 (1998) 1108-1112
25. Tohyama M., Yahata Y., Yasukawa M., Inagi R., Urano Y., Yamanishi K., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134 (1998) 1113-1117
26. Asada H., Miyagawa S., Sumikawa Y., Yamaguchi Y., Itami S., Suguri S., et al. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch Dermatol 139 (2003) 1601-1607
27. Hurme M., Haanpaa M., Nurmikko T., Wang X.Y., Virta M., Pessi T., et al. IL-10 gene polymorphism and herpesvirus infections. J Med Virol 70 Suppl 1 (2003) S48-S50
28. McKenna D.B., Neill W.A., and Norval M. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences. Br J Dermatol 144 (2001) 459-464